Home » Authors » Nuala Moran

Articles by Nuala Moran

Antisoma Seeks Licensing Deal Due To Time Frame Of Phase III

Aug. 28, 2002

PPL Therapeutics Produces Double Gene Knockout Piglets

Aug. 28, 2002

Amoebics Formed To Exploit Amoeba's Bacteria Absorption

Aug. 21, 2002

CeNeS Spinout Xention Focuses On Screening Of Ion Channels

Aug. 21, 2002

CeNeS Spinout Xention Focuses On Screening Of Ion Channels

Aug. 21, 2002

Amoebics Formed To Exploit Amoeba's Bacteria Absorption

Aug. 21, 2002

British Biotech Collaborates With GeneSoft In Anti-Infectives Deal

Aug. 14, 2002

Evolutec Raises £1.8 Million In Third Round Of Financing

Aug. 14, 2002

Phico Raises £450,000 To Begin Antibiotic Development

Aug. 14, 2002

British Biotech Collaborates With GeneSoft In Anti-Infectives Deal

Aug. 14, 2002

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...